Kisspeptin-10
Kisspeptin-10
Kisspeptin-10 is used in hormone optimization discussions, but it remains in the restricted compounding bucket.
Current status
Restricted
Hormone-related interest, with current federal compounding constraints still in play.
FDA category
Category 2
Can pharmacies compound this?
No
Reclassification expected?
Yes
Less publicly visible than BPC-157 but still part of the same regulatory conversation.
Primary Use
Hormone-related interest
Regulatory Timeline
Feb 27, 2026
Political pressure and market expectations increased around a future peptide reclassification review.
Sep 29, 2023
Current status signal recorded: Restricted by current FDA category treatment..
Mar 15, 2023
FDA peptide compounding scrutiny intensified across 503A and 503B channels.
Get notified...
Get notified when Kisspeptin-10 status changes
State-specific notes
Texas
Usually replaced by more established hormonal therapies.